Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

Presentation TVT 2016

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Thomas Walther

June 16, 2016

$Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis$

Presentation JIM 2016

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

Presenter: Paolo Pagnotta

February 12, 2016

Presentation JIM 2016

ACURATE Neo: Top-down deployment translates into stable, precise positioning and successful procedures: Symetis TAVI programme highlights

Presenter: Christian Hengstenberg

February 10, 2016

News Daily News

新前沿：可重新定位、可回收的经导管瓣膜在治疗非钙化性主动脉瓣关闭不全方面颇具前景

Yael L. Maxwell

November 24, 2015

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

News Daily News

La Última Frontera: Válvulas Reposicionables, Recuperables y Transcatéter en el Manejo de la Regurgitación Aórtica No Calcificada

Yael L. Maxwell

November 24, 2015

Presentation TCT 2015

CE-Approved or EU Studies: ACURATE Procedural Considerations and Case Examples

Presenter: Martin B. Leon, Nicolo Piazza, Alexandre Abizaid

October 14, 2015

Presentation TCT 2015

CE-Approved or EU Studies: ACURATE Technical Specifications and Clinical Trial Results (CE Study and Other EU Results)

Presenter: Martin B. Leon, Nicolo Piazza, Helge Möllmann

October 14, 2015

Presentation TCT 2014

ACURATE - Technology Review, Clinical Results, and Case Examples

Presenter: Helge Möllmann

September 15, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Industry News

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

September 12, 2014

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

News Daily News

先前肾损伤、低体重易致TAVR后急性肾损伤

August 07, 2014

News Daily News

Un Deterioro Renal Anterior y el Bajo Peso Corporal Predisponen a padecer Lesión Renal Aguda Post-TAVR

August 07, 2014

News Daily News

Prior Renal Impairment, Low Body Weight Predispose to Acute Kidney Injury After TAVR

August 07, 2014

Presentation TVT 2014

ACURATE TF - Technology Review, Clinical Results, and Case Examples

Presenter: Helge Möllmann

June 05, 2014

Presentation TCT 2013

ACURATE TF: Technology, Clinical Results, and Case Examples

Presenter: Helge Moellmann

October 28, 2013

Presentation TCT 2013

ACURATE TA: Technology, Clinical Results, and Case Examples

Presenter: Thomas Walther

October 28, 2013

Presentation TVT 2013

ACURATE Transapical

Presenter: Thomas Walther

June 13, 2013

Advertisement

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

ACURATE Neo: Top-down deployment translates into stable, precise positioning and successful procedures: Symetis TAVI programme highlights

新前沿：可重新定位、可回收的经导管瓣膜在治疗非钙化性主动脉瓣关闭不全方面颇具前景

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

La Última Frontera: Válvulas Reposicionables, Recuperables y Transcatéter en el Manejo de la Regurgitación Aórtica No Calcificada

CE-Approved or EU Studies: ACURATE Procedural Considerations and Case Examples

CE-Approved or EU Studies: ACURATE Technical Specifications and Clinical Trial Results (CE Study and Other EU Results)

ACURATE - Technology Review, Clinical Results, and Case Examples

TCT Course Director Outlines Current TAVR Controversies

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

先前肾损伤、低体重易致TAVR后急性肾损伤

Un Deterioro Renal Anterior y el Bajo Peso Corporal Predisponen a padecer Lesión Renal Aguda Post-TAVR

Prior Renal Impairment, Low Body Weight Predispose to Acute Kidney Injury After TAVR

ACURATE TF - Technology Review, Clinical Results, and Case Examples

ACURATE TF: Technology, Clinical Results, and Case Examples

ACURATE TA: Technology, Clinical Results, and Case Examples

ACURATE Transapical

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content